Otwarty dostęp

Parathyroidectomy in a patient treated with emicizumab

Helen Hupston

Helen Hupston

University Hospital, Queen Elizabeth Hospital BirminghamBirmingham, UK
Profil Orcid
Wyszukaj tego autora
Sciendo|Google Scholar
Hupston, Helen
  
23 gru 2019
Parathyroidectomy in a patient treated with emicizumab's Cover Image
O artykule
Poprzedni artykuł
Następny artykuł
Zacytuj
Pobierz okładkę
Data publikacji: 23 gru 2019
Zakres stron: 51 - 53
DOI: https://doi.org/10.17225/jhp00149
Słowa kluczowe
© 2019 Helen Hupston, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
A patient with haemophilia A and inhibitors undergoing parathyroidectomy continued a standard maintenance dose of emicizumab, with bleed risk managed intra- and postoperatively with recombinant Factor VIIa (rFVIIa) and tranexamic acid. Despite the risk of hypercoagulability with the combination of emicizumab and rFVIIa, no postoperative complications were reported.© Shutterstock
A patient with haemophilia A and inhibitors undergoing parathyroidectomy continued a standard maintenance dose of emicizumab, with bleed risk managed intra- and postoperatively with recombinant Factor VIIa (rFVIIa) and tranexamic acid. Despite the risk of hypercoagulability with the combination of emicizumab and rFVIIa, no postoperative complications were reported.© Shutterstock
Język:
Angielski
Częstotliwość wydawania:
1 razy w roku
Dziedziny czasopisma:
Medycyna, Podstawowe nauki medyczne, Podstawowe nauki medyczne, inne, Medycyna kliniczna, Medycyna kliniczna, inne, Farmacja, Farmakologia
Kanał RSS czasopisma